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Nonmelanoma skin cancers (NMSC) are the most 
frequently diagnosed cancers in Australia and their 
incidence is increasing.1 Over 50% of the population 
will develop an NMSC in their lifetime2 and 2% require 
treatment each year.3 This results in NMSC being the 
most expensive cancer to treat.4 The clinical diagnosis 
of NMSC is often difficult and has been shown to be 
inaccurate, even by specialist dermatologists.5 Benign 
lesions such as keratoacanthomas and seborrheic 
keratoses are easily mistaken for squamous cell 
carcinomas (SCCs) and basal cell carcinomas (BCCs). 
Conversely, NMSC is frequently undiagnosed, even in 
highly visible sites.6 
	
Accurate	 diagnosis	 of	 NMSC	 depends	 on	 histology,	 as	
does	Medicare	 reimbursement.7,8	 Skin	 cancer	 care	 in	
Australia	 is	provided	 in	 a	wide	 range	of	primary	 care	 and	
specialist	settings,	and	there	has	been	much	recent	debate	
regarding	the	quality	of	care	provided	in	each.9	In	Tasmania	
–	where	 this	 study	was	 conducted	 –	 there	 has	 not	 yet	
been	 a	 large	 scale	 expansion	of	 specialist	 skin	 clinics.	At	
the	time	of	this	study,	all	primary	care	of	skin	lesions	was	
within	traditional	general	practice	(although	some	practices	
advertise	a	special	interest	in	skin	cancer	care).	
	 Much	 of	 the	 quality	 of	 care	 debate	 has	 so	 far	 been	
focused	on	melanoma	skin	cancers	where	it	is	known	that	
a	 very	 large	 number	 of	 pigmented	 lesions	 are	 removed	
in	 order	 to	 identify	melanomas.	The	 rate	 of	malignancy	
among	 excised	 pigmented	 lesions	 has	 been	 shown	 to	
be	 as	 low	as	 8%,	 requiring	 12.5	 lesions	 to	 be	 treated	 in	
order	 to	 identify	 one	melanoma.10	The	 removal	 of	 this	
large	number	of	benign	lesions	may	result	in	unnecessary	
procedures,	patient	suffering,	and	costs.
	 Despite	 the	 much	 higher	 incidence	 of	 NMSC,	
there	 is	 less	 known	 about	 the	 rate	 of	 malignancy	
among 	 exc i s ed 	 o r 	 b i o p s i ed 	 nonp i gmen ted	
lesions.	 The	 aim	 of	 this	 study	 was	 to	 determine	
the	number	of	nonpigmented	 lesions	excised	or	biopsied	
in	 a	 community	 setting	 and	 referred	 for	 histology	
in	 order	 to	 identify	 mal ignant	 and	 pre- invasive	
nonmelanocytic	lesions.
Method
Histology	 reports	 relating	 to	 nonpigmented	 skin	
samples	 processed	 during	 January	 2005	were	 accessed	
retrospectively	 from	 the	 database	 of	 two	 laboratories	 of	
the	major	 skin	 histopathology	 provider	 in	Tasmania.	Both	
punch	and	excision	biopsies	were	included.	The	number	of	
NMSC	notifications	from	these	two	centres	was	compared	
with	 the	 state	 total	 as	 reported	 to	 the	Tasmanian	Cancer	
Registry	 and	 it	 was	 found	 to	 represent	 69%	 of	 SCCs	
(132/192)	and	72%	of	BCCs	(289/399)	notified	in	Tasmania	
during	that	month.	
	 Reports	were	included	in	the	sample	when	they	were	
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BACKGROUND 
Nonmelanoma skin cancer (NMSC) is the most common cancer in Australia and thus the most costly to treat. Despite the 
high prevalence of NMSC, little is known about the rate of malignancy in excised or biopsied nonpigmented lesions.
METHOD
An audit of 912 reports relating to nonpigmented skin samples from 749 patients processed during January 2005 in Tasmania.
RESULTS
Nonmelanoma skin cancer was present in 60.6% of samples from specialists and 44.5% from nonspecialists/primary care 
doctors (p<0.001); 1.6 skin lesions were excised or biopsied in order to identify one malignant or pre-invasive lesion (1.3 
for specialists and 1.7 for nonspecialists). The number of NMSCs increased with age and were more common in men. 
DISCUSSION 
Medical practitioners are efficient in their management of nonpigmented skin lesions in both primary and secondary care.
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the	 initial	 specimen	 received	 for	 any	 given	
nonpigmented	 lesion.	They	were	 not	 included	
if	 they	 related	 to	 an	 excision	 or	 re-excision	
following	 an	 earlier	 biopsy	 or	 incomplete	
excision,	 or	 if	 the	 macroscopic	 description	
included	 the	 term	 ‘pigmented’	 (eg.	 pigmented	
seborrheic	 keratoses	 or	 pigmented	 basal	 cell	
carcinomas).
	 Data	 collected	 included	 the	 histological	
diagnosis,	 sample	 type	 (biopsy	 or	 excision),	
patient	 gender	 and	date	of	 birth,	 and	 category	
of	 referring	 doctor	 (specialist	 or	 nonspecialist).	
Diagnoses	were	 categorised	 as	 ‘benign’,	 ‘pre-
malignant’,	‘pre-invasive’	or	‘malignant’.	Results	
were	 analysed	 using	 SPSS	 for	Windows™	
release	 11.	 Standard	 bivariate	 statistical	 tests	
(such	as	Pearson’s	correlation	coefficient	 r,	and	
Chi-square	tests)	were	used	for	comparisons.
Results
A	 total	of	749	patients	had	912	nonpigmented	
skin	 samples	 examined	 by	 the	 participating	
laboratories	 in	Tasmania	 during	 January	 2005.	
The	 subjects	 had	 an	 average	 age	 of	 64.7	
years	 (SD=14.5)	 and	 53.0%	were	male.	Most	
subjects	 (84.2%)	 had	 only	 one	 skin	 lesion	
treated	 during	 the	 study	 period;	 one	 patient	
had	six	skin	lesions	treated.	
	 Nonmelanoma	 skin	 cancer	was	more	 likely	
to	be	 found	 in	complete	excision	samples	 than	
in	 punch	 biopsy	 samples	 (at	 least	 one	NMSC	
identified	 per	 patient:	 53.0–41.6%	 respectively;	
p=0.011).	The	 histological	 diagnoses	 of	 both	
excised	 and	 biopsied	 lesions	 are	 shown	 in	
Table 1.	There	 were	 no	 instances	 found	 of	
rare	 lesions	 such	 as	 lymphoma	 and	 sarcoma	
of	 the	 skin,	 appendageal	 tumour,	 and	 amel-
anotic	melanoma.	
	 Three	 hundred	 and	 eighty-one	 patients	
(50.9%)	had	no	malignant	skin	lesion	identified	
by	 histology,	 43.9%	 had	 one,	 32	 (4.3%)	 had	
two,	 four	 (0.5%)	 had	 three,	 one	 (0.1%)	 had	
four,	and	two	patients	 (0.2%)	had	five	NMSCs	
identified	during	the	1	month	study	period.	The	
number	of	NMSCs	identified	increased	with	the	
age	of	the	patient	(R=0.17,	p<0.001).	Men	were	
more	likely	to	have	NMSC	identified	compared	
to	women	(at	 least	one	NMSC	identified:	57.7-
39.5%;	p<0.001).	
	 A	 higher	 rate	 of	 NMSC	was	 identified	 in	
samples	 collected	 by	 special ist	 doctors	
compared	 to	 nonspecialists	 (Table 2).	There	
was	 a	 positive	 finding	 per	 patient	 sampled	
of	 60.6%	 for	 special ists	 and	 44.5%	 for	
nonspecialists	 (p<0.001).	 Overall,	 582	 of	
912	 lesions	 (63.8%)	were	malignant	 or	 pre-
invasive	 (SCC	 in	 situ).	Thus,	 1.6	 skin	 lesions	
were	 excised	 or	 biopsied	 in	 order	 to	 identify	
one	 malignant	 or	 pre-invasive	 lesion.	 For	
specialists	the	number	needed	to	treat	was	1.3	
(215	 histology	 positive	 from	 279	 lesions)	 and	
for	 nonspecialists	 the	 number	 needed	 to	
treat	 was	 1.7	 (367	 of	 633).	 Nonspecialist	
doctors	 generated	 71.2%	 of	 pathology	
Table 1. Histologic classification of skin lesions 
Diagnostic category Histological diagnoses Excised lesions Biopsied lesions  All lesions  
  n=582 (%)  n=330 (%)  n=912 (%)
Benign	 Keratoses	 16		 (2.7)	 24		 (7.2)	 40		 (4.4)
	 Keratoacanthoma	 5		 (0.9)	 1		 (0.3)	 6		 (0.7)
	 Seborrheic	keratosis	(nonpigmented)	 50		 (8.6)	 25		 (7.6)	 75		 (8.2)
	 Neurofibroma	 4		 (0.7)	 0	 	 4		 (0.4)
	 Scar	tissue	 2		 (0.3)	 2		 (0.6)	 4		 (0.4)
	 Dermatofibroma	 25		 (4.3)	 5		 (1.5)	 30		 (3.3)
	 Chondrodermatitis	nodularis	chronica	helicis	 3		 (0.5)	 2		 (0.6)	 5		 (0.5)
	 Lichen	simplex	chronicus	 9		 (1.5)	 6		 (1.8)	 15		 (1.6)
	 Sebaceous	hyperplasia	 1		 (0.2)	 3		 (0.9)	 4		 (0.4)
	 Verruca	vulgaris	 6		 (1.0)	 2		 (0.6)	 8		 (0.9)
	 Squamous	papilloma	 4		 (0.7)	 0	 	 4		 (0.4)
	 Subtotal	 125		 (21.5)	 70		 (21.2)	 195		 (21.4)
Premalignant	 Solar	keratosis*	 61		 (10.5)	 74		 (22.4)	 135		 (14.8)
Pre-invasive	 Squamous	cell	carcinoma	in	situ	(Bowen’s	disease)	 105		 (18.0)	 58		 (17.6)	 163		 (17.9)
Malignant	 Basal	cell	carcinoma	 191		 (32.8)	 97		 (29.4)	 288		 (31.6)
	 Squamous	cell	carcinoma	 100		 (17.2)	 31		 (9.4)	 131		 (14.4)
*	The	exact	classification	of	solar	keratosis	as	premalignant	or	essentially	benign	remains	contentious	
Table 2. Histology by type of referring doctor
Type of lesion Treated by Treated by  
 nonspecialist n=633 (%)  specialist n=279 (%)
Benign	lesion	(n=195)	 163		 (25.8)	 32		 (11.5)
Solar	keratosis	(n=135)	 103		 (16.3)	 32		 (11.5)
SCC	in	situ	(n=163)	 109		 (17.2)	 54		 (19.4)
SCC	(n=288)	 176		 (27.8)	 112		 (40.1)
BCC	(n=131)	 82		 (13.0)	 49		 (17.6)
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referrals,	 resulting	 in	63%	of	 identified	NMSC	
and	SCC	in	situ.	
Discussion
The	overall	number	needed	to	treat	of	1.6	shows	
a	 high	 yield	 for	 detecting	malignant	 or	 pre-
invasive	lesions	from	nonpigmented	lesions.	The	
comparable	 rate	 found	 for	 pigmented	 lesions	
in	 previous	 studies	 is	 12.5.10	This	 difference	 is	
probably	 due	 to	 the	 generally	 less	 aggressive	
course	of	NMSC	and	treating	doctors’	increased	
comfort	 level	 regarding	 the	 risk	 of	 missed	
lesions.	The	 rate	 of	 positive	 histology	 was	
higher	 in	males	 than	 females	 and	 increased	
with	 increasing	 age.	This	 finding	 is	 consistent	
with	the	known	incidence	of	NMSC.1	The	rate	of	
totally	benign	lesions	among	nonpigmented	skin	
samples	was	low	at	22%.
	 This	 study	 did	 not	 have	 access	 to	 the	
treating	 doctor’s	 reason	 for	 excision.	 It	 was	
assumed	 that	 nonpigmented	 samples	 referred	
for	 histology	 had	 been	 identified	 as	 potential	
NMSC	 or	 other	 skin	 tumours,	 however	 this	
may	 not	 always	 have	 been	 the	 case.	 Other	
reasons	for	excision	may	include	cosmesis,	itch,	
or	 patient	 request.	However,	 lesions	 removed	
for	these	reasons	may	be	 less	 likely	to	be	sent	
for	histopathology.	
	 The	 higher	 rate	 of	 malignancy	 among	
excision	 samples	 suggests	 doctors	were	more	
likely	 to	 excise	 lesions	 believed	 to	 be	NMSC,	
while	merely	taking	biopsies	from	lesions	with	a	
less	certain	clinical	diagnosis.
	 It	 was	 found	 that	 the	 majority	 (63%)	 of	
NMSCs	were	 identified	 in	 samples	 received	
from	 nonspecialist	 doctors	 (in	Tasmania	 this	
largely	 represents	 general	 practitioners)	which	
concurs	with	 previous	 findings.1	The	 number	
of	 lesions	 needed	 to	 treat	 was	 higher	 for	
nonspecialist	 (GP)	 than	 specialist	 doctors	 (1.7	
compared	with	 1.3).	This	 is	 likely	 to	 reflect	 the	
lower	 prevalence	 of	 NMSC	 in	 an	 unselected	
population	 attending	 nonspecialist	 doctors	
compared	to	the	higher	risk,	filtered	populations	
referred	to	specialists.	It	should	not	be	assumed	
to	reflect	a	difference	in	diagnostic	accuracy.		
	 These	 results	 suggest	 that	 medical	
practitioners	 are	 efficient	 in	 their	management	
of	 nonpigmented	 skin	 lesions.	There	 are	 few	
lesions	 sampled	 or	 excised	 unnecessarily.	 It	
is	 not	 known	 how	 many	 NMSCs	 remain	
undiagnosed	 but	 the	 number	 is	 believed	 to	
be	 substantial.6	 Efforts	 to	 further	 reduce	 the	
number	of	nonpigmented	lesions	sampled	might	
increase	the	number	of	undiagnosed	lesions.	
Implications for general practice
•	 	The	majority	 of	 care	 for	 NMSC	 occurs	 in	
general	practice	
•	 	GPs	are	efficient	and	effective	in	their	use	of	
biopsy	 and	excision	 for	 the	management	 of	
NMSC.
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